This five-year study examines the effectiveness of buprenorphine treatment provided to
previously-addicted inmates(N=320; 160 males, 160 females) initiated in prison and continued
in the community. The study also examines the extent to which the setting of post-release
buprenorphine is provided.It is expected that participants receiving in-prison buprenorphine
will have superior outcomes compared to participants who did not receive in-prison
buprenorphine.
Phase:
Phase 3
Details
Lead Sponsor:
Friends Research Institute, Inc.
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Analgesics, Opioid Buprenorphine Buprenorphine, Naloxone Drug Combination